They discussed the importance of a marginal influx of host cells into the implanted construct and a marginal efflux of donor cells into surrounding tissues for integration between host and donor. the transplantation of PLA without cells, the defects were not repaired with hyaline cartilage. The cartilaginous matrix by safranin O staining and type II collagen by immunohistochemical staining were recognized, however the PLA matrix was still present in the defects at 24 weeks after transplantation of the construct. During the time passage, transplanted MCs numbers decreased from 7.8 105 at 1 week, to 3.5 105 at 4 weeks, and to 3.8 104 at 12 weeks. Transplanted MCs were not detectable at 24 weeks. == Conclusions == MCs contribute to the osteochondral repair expressing the cartilaginous matrix, however the number of MCs were decreasing with time (i.e. 24 weeks). These results could be essential for achieving cartilage regeneration by cell transplantation strategies with growth factors and/or gene therapy. == Introduction == Osteoarthritis(OA)is one of the most commondiseases, with more than 20 million people affected in the United States. It is characterized as degeneration of articular cartilage Mouse monoclonal to EphB3 and underlying subchondral bone.1For patients with advanced OA, there are several surgical options, such as chondroplasty, drilling, and microfracture to induce cartilage repair25; autologous and allogenic osteochondral transplantations as cartilage replacement procedures68; and artificial joint replacement and arthrodesis as Ginkgetin salvage procedures.9Though clinical results are generally positive, there are known problems and these procedures do not involve cartilage regeneration.1014 Autologous chondrocyte implantation (ACI) has been reported as a cartilage reconstruction trial.15The clinical procedures have been quite successful, and this is currently one of the Ginkgetin best surgical options, especially for young, active patients. However, there are several limitations to this procedure, including the limited availability of harvested cartilage, the dedifferentiation of chondrocytesin vitro, degeneration at the harvest site, flow of cell suspension from the transplanted area, and hypertrophy of the periosteal membrane at the transplanted area.1620To resolve these issues, modified trials with various cell sources and scaffolds are being established and additional strategies such as the use of growth factors and/or gene therapy have been attempted. However, the regeneration of genuine, long-lasting, normal cartilage has not yet been successful. We hypothesized that the survivability and behavior of transplanted cells need to be examined clearly to achieve cartilage regeneration with cell-based Ginkgetin treatment. The fate of the cells in the transplanted area has not been explained because of the difficulty in distinguishing transplanted cells from the host cellsin vivo. Thus, the ability of transplanted cells to survive and contribute to the repair in the transplanted area has not been well discussed. This Information could provide the most effective timing for performing additional treatments during the repair process. Chondrocytes are a suitable source for the repair of cartilage defects that do not penetrate the subchondral bone. However, an osteochondral defect involves both cartilage and subchondral bone (Grade 4 by classification of the International Cartilage Repair Society), and thus chondrocytes may not be adequate for osteochondral repair.21 Mesenchymal stem cells (MSCs) have the capacity for self-duplication and the potential to differentiate into several mesenchymal tissues (i.e., bone, cartilage, tendon, muscle, and fat tissues).22,23MSCs exist in bone marrow and many other tissues and can be harvested from bone marrow by a minor invasive procedure clinically. MSCs can also be cultured and increased to sufficient numbersin vitrowhile preserving their multipotent differentiation capacity. We previously reported the.